ADvTECH Toekomstige groei

Future criteriumcontroles 2/6

De verwachting is dat ADvTECH de winst en omzet met respectievelijk 12.2% en 8.9% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 12.1% per jaar.

Belangrijke informatie

12.2%

Groei van de winst

12.1%

Groei van de winst per aandeel

Consumer Services winstgroei	26.2%
Inkomstengroei	8.9%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	08 Oct 2024

Recente toekomstige groei-updates

Recent updates

With ADvTECH Limited (JSE:ADH) It Looks Like You'll Get What You Pay For

Jul 05

ADvTECH (JSE:ADH) Has Announced That It Will Be Increasing Its Dividend To ZAR0.57

Mar 28

Do Its Financials Have Any Role To Play In Driving ADvTECH Limited's (JSE:ADH) Stock Up Recently?

Jan 25

Should You Be Impressed By ADvTECH's (JSE:ADH) Returns on Capital?

Dec 28

A Look At ADvTECH's (JSE:ADH) Share Price Returns

Dec 15

Is ADvTECH (JSE:ADH) Using Too Much Debt?

Dec 03

What Type Of Shareholders Make Up ADvTECH Limited's (JSE:ADH) Share Registry?

Nov 20

Winst- en omzetgroeiprognoses

JSE:ADH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (ZAR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	10,260	1,392	1,493	1,326	1
12/31/2025	9,380	1,239	1,346	1,187	1
12/31/2024	8,646	1,101	1,058	1,091	1
6/30/2024	8,202	1,026	859	1,535	N/A
3/31/2024	8,031	989	784	1,456	N/A
12/31/2023	7,860	951	708	1,377	N/A
9/30/2023	7,686	923	682	1,399	N/A
6/30/2023	7,512	895	655	1,422	N/A
3/31/2023	7,236	850	598	1,341	N/A
12/31/2022	6,961	805	540	1,260	N/A
9/30/2022	6,699	765	672	1,263	N/A
6/30/2022	6,438	724	805	1,265	N/A
3/31/2022	6,178	695	792	1,194	N/A
12/31/2021	5,917	665	780	1,122	N/A
9/30/2021	5,724	627	778	1,074	N/A
6/30/2021	5,531	590	777	1,025	N/A
3/31/2021	5,515	525	686	962	N/A
12/31/2020	5,499	461	595	899	N/A
9/30/2020	5,468	437	433	899	N/A
6/30/2020	5,437	412	271	898	N/A
3/31/2020	5,273	441	108	762	N/A
12/31/2019	5,108	469	-55	626	N/A
9/30/2019	4,910	457	73	666	N/A
6/30/2019	4,713	445	201	706	N/A
3/31/2019	4,551	416	131	661	N/A
12/31/2018	4,389	386	61	616	N/A
9/30/2018	4,251	364	-24	620	N/A
6/30/2018	4,113	341	-108	624	N/A
3/31/2018	4,025	354	N/A	602	N/A
12/31/2017	3,938	367	N/A	580	N/A
9/30/2017	3,827	378	N/A	595	N/A
6/30/2017	3,715	390	N/A	610	N/A
3/31/2017	3,534	381	N/A	533	N/A
12/31/2016	3,353	372	N/A	456	N/A
9/30/2016	3,210	341	N/A	462	N/A
6/30/2016	3,068	309	N/A	469	N/A
3/31/2016	2,888	267	N/A	404	N/A
12/31/2015	2,708	225	N/A	340	N/A
9/30/2015	2,479	208	N/A	317	N/A
6/30/2015	2,250	191	N/A	294	N/A
3/31/2015	2,091	179	N/A	246	N/A
12/31/2014	1,932	167	N/A	198	N/A
9/30/2014	1,888	166	N/A	242	N/A
6/30/2014	1,844	165	N/A	285	N/A
3/31/2014	1,805	160	N/A	292	N/A
12/31/2013	1,766	156	N/A	299	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei ADH ( 12.2% per jaar) ligt boven de spaarquote ( 9.7% ).

Winst versus markt: De winst van ADH ( 12.2% per jaar) zal naar verwachting langzamer groeien dan de markt ZA ( 21.7% per jaar).

Hoge groeiwinsten: De winst van ADH zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van ADH ( 8.9% per jaar) zal naar verwachting sneller groeien dan de markt ZA ( 3.6% per jaar).

Hoge groei-inkomsten: De omzet van ADH ( 8.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ADH naar verwachting over 3 jaar hoog zal zijn

ADvTECH Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

ADvTECH Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Recent updates

Insider recently sold R1.9m worth of stock

Insider recently sold R4.1m worth of stock

Insider recently sold R309k worth of stock

First half 2024 earnings released: EPS: R0.98 (vs R0.84 in 1H 2023)

ADvTECH Limited Announces the Declaration of an Interim Dividend in Respect of the Six Months Ended 30 June 2024, Payable on 16 September 2024

ADvTECH Limited to Report Q2, 2024 Results on Aug 26, 2024

With ADvTECH Limited (JSE:ADH) It Looks Like You'll Get What You Pay For

ADvTECH Limited Announces Retirement of Didier Oesch as CFO, Effective End of April 2025

Group Commercial Director recently sold R3.9m worth of stock

Insider recently sold R1.6m worth of stock

Upcoming dividend of R0.57 per share

ADvTECH (JSE:ADH) Has Announced That It Will Be Increasing Its Dividend To ZAR0.57

Final dividend increased to R0.57

Full year 2023 earnings released: EPS: R1.74 (vs R1.49 in FY 2022)

ADvTECH Limited, Annual General Meeting, Jun 05, 2024

New minor risk - Financial data availability

ADvTECH Limited Appoints GD Whyte to Transformation, Social & Ethics Committee and the Investment Committee

ADvTECH Limited Announces CEO Changes

Insider recently sold R2.4m worth of stock

Insider recently sold R2.6m worth of stock

Group CEO & Executive Director exercised options to buy R12m worth of stock.

ADvTECH Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023

Insider recently sold R205k worth of stock

Upcoming dividend of R0.30 per share at 3.2% yield

Advtech Limited Announces Board Changes

ADvTECH (JSE:ADH) Will Pay A Larger Dividend Than Last Year At ZAR0.30

First half 2023 earnings released: EPS: R0.84 (vs R0.68 in 1H 2022)

ADvTECH Limited Declares an Interim Dividend in Respect of the Six Months Ended 30 June 2023, Payable on 18 September 2023

ADvTECH Limited to Report First Half, 2023 Results on Aug 28, 2023

Upcoming dividend of R0.37 per share at 3.3% yield

Full year 2022 earnings released: EPS: R1.49 (vs R1.23 in FY 2021)

ADvTECH (JSE:ADH) Will Pay A Larger Dividend Than Last Year At ZAR0.37

Now 20% undervalued after recent price drop

Now 21% undervalued

Insider recently sold R1.5m worth of stock

High number of new directors

Insider exercised options and sold R63k worth of stock

Insider recently sold R901k worth of stock

Group Commercial Director recently sold R1.7m worth of stock

ADvTECH Limited Appoints Alexandra Watson as an Independent Non-Executive Director, Effective on November 1, 2022

Upcoming dividend of R0.23 per share

ADvTECH Limited to Report First Half, 2022 Results on Aug 29, 2022

Upcoming dividend of R0.31 per share

Now 20% undervalued

Now 21% undervalued after recent price drop

Now 25% undervalued after recent price drop

Group CEO & Executive Director exercised options to buy R821k worth of stock.

Group Academic Director recently sold R243k worth of stock

High number of new directors

Investor sentiment improved over the past week

Group Academic Director recently sold R120k worth of stock

Investor sentiment improved over the past week

First half 2021 earnings released: EPS R0.57 (vs R0.34 in 1H 2020)

Independent Non-Executive Director Jens Zimmermann has left the company

Independent Non-Executive Director Jane Hofmeyr has left the company

Upcoming dividend of R0.20 per share

Full year 2020 earnings released

Group Academic Director recently sold R91k worth of stock

ADvTECH Limited Announces Mr. Jens Zimmermann Not Stand for Re-Election as Director

ADvTECH Limited Appoints Clive Bradney Thomson as Independent Non-Executive Director

ADvTECH Limited Announces Dr. Jane Hofmeyr Do Not Stand for Re-Election At Agm

Value Capital Partners acquired an unknown stake in ADvTECH Limited.

New 90-day high: R11.46

Have Insiders Been Selling ADvTECH Limited (JSE:ADH) Shares?

New 90-day high: R10.03

Do Its Financials Have Any Role To Play In Driving ADvTECH Limited's (JSE:ADH) Stock Up Recently?

New 90-day high: R9.83

Should You Be Impressed By ADvTECH's (JSE:ADH) Returns on Capital?

A Look At ADvTECH's (JSE:ADH) Share Price Returns

Advtech Limited Announces Executive Changes

Is ADvTECH (JSE:ADH) Using Too Much Debt?

New 90-day high: R9.50

Insider recently sold R1.4m worth of stock

What Type Of Shareholders Make Up ADvTECH Limited's (JSE:ADH) Share Registry?